Connect Sign In
ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.
ARUP’s Clinical Trials and PharmaDx groups supported Blueprint Medicines’ clinical trials that led to FDA approval for AYVAKIT® (avapritinib), a new treatment for indolent systemic mastocytosis.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on autoimmune neurologic diseases, drug detection in newborns, and common variable immunodeficiency.
ARUP Section Chief Joely Straseski, PhD, will address lab testing for transgender individuals at the 2023 National Transgender Health Summit and the Mountain West Transforming Care Conference.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on hypopituitarism, diabetes mellitus, and endocrine testing in transgender adults.
ARUP’s new test to detect Candida auris will offer a robust screening tool to help clinical facilities identify patients colonized with the yeast and guide infection prevention measures.
We are kickstarting Lab Week by putting a spotlight on the important role that medical laboratory professionals have in improving and saving patient lives.
Tickborne diseases such as babesiosis are on the rise in the United States and are primarily transmitted during the summer months when ticks are most active.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for chronic myeloid leukemia, measles, and genital ulcer diseases.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on complement deficiency testing, hereditary cancer assessment, and rapid whole genome sequencing.
